Analystreport

Adaptive Biotechnologies Co. (NASDAQ: ADPT) had its "neutral" rating re-affirmed by analysts at The Goldman Sachs Group, Inc.. They now have a $63.00 price target

Adaptive Biotechnologies Corporation  (ADPT) 
Last adaptive biotechnologies corporation earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: adhc.com